These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 84709)

  • 1. Immunogenicity of chemically induced murine colon cancers.
    Belnap LP; Cleveland PH; Colmerauer ME; Barone RM; Pilch YH
    Cancer Res; 1979 Apr; 39(4):1174-9. PubMed ID: 84709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure.
    Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
    Cancer Res; 1975 Sep; 35(9):2434-9. PubMed ID: 1149045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation immunity and cross-protection of two cultured murine colon lines.
    Sato N; Michaelides MC; Wallack MK
    J Natl Cancer Inst; 1983 Feb; 70(2):261-5. PubMed ID: 6571935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of specific active immunization on tumor recurrence following primary tumor resection in WF rats with 1,2-dimethylhydrazine-induced bowel cancer.
    Ross DS; Steele G; Madara J; Lahey SJ; Ravikumar TS; Wilson RE; Munroe AE; Wright D; King VP
    J Natl Cancer Inst; 1984 Sep; 73(3):731-5. PubMed ID: 6590917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats.
    Jamasbi RJ; Nettesheim P
    Cancer Res; 1977 Nov; 37(11):4059-63. PubMed ID: 71203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
    Sato N; Kikuchi K
    J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic results obtained with an experimental system oftransplantable colonic tumors. Possible applications of these results to human intestinal tumors].
    Martin MS; Martin F
    Bull Cancer; 1975; 62(4):439-44. PubMed ID: 174767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats.
    Jamasbi RJ; Nettesheim P; Kennel SJ
    Cancer Res; 1978 Feb; 38(2):261-7. PubMed ID: 340026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay.
    Economou GC; Takelchi N; Boone CW
    Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface antigens in a rat colon cancer model: correlation with inhibition of tumor growth.
    Steele G; Sjogren HO
    Surgery; 1977 Jul; 82(1):164-9. PubMed ID: 877853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tumor rejection antigen molecules of chemically induced murine colon tumor C-C26.
    Sato N; Yagihashi A; Okubo M; Torigoe T; Takahashi S; Sato T; Kikuchi K
    Cancer Res; 1987 Jun; 47(12):3147-51. PubMed ID: 3581064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-mediated changes of tumour cell immunogenicity and antigenicity.
    Puccetti P; Romani L; Taramelli D; Bonmassar E; Fioretti MC
    Int J Tissue React; 1982; 4(3):189-99. PubMed ID: 6183194
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effect of oral Salmonella enteritidis 11RX infection against colon tumor induction by 1,2-dimethylhydrazine in mice.
    Ashman LK; Cook MG; Kotlarski I
    Cancer Res; 1979 Jul; 39(7 Pt 1):2768-71. PubMed ID: 376122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current questions on the tumour-associated antigens of chemically-induced tumours II. In search of practical uses.
    Oth D
    Biomedicine; 1976 Jan; 24(1):4-10. PubMed ID: 57809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K; Bahar R; Natsume W; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell response to tumor antigens is associated with depletion of B progenitors in murine colocarcinoma.
    Kirman I; Huang EH; Whelan RL
    Surgery; 2004 Mar; 135(3):313-8. PubMed ID: 14976482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer.
    Soloway MS; Martino C; Hyatt C; Marrone JC
    Natl Cancer Inst Monogr; 1978 Dec; (49):293-300. PubMed ID: 748783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of BCG immunotherapy on kinetic parameters and growth curves of 5 transplantable lines of colon carcinoma chemically induced in rat (author's transl)].
    Martin MS; Martin F; Justrabo E; Michel MF; Lagneau A
    Gastroenterol Clin Biol; 1979 Mar; 3(3):247-53. PubMed ID: 456820
    [No Abstract]   [Full Text] [Related]  

  • 19. Demonstration of effective antitumor immunity in an autochthonous host bearing primary colon tumors induced by 1,2-dimethylhydrazine dihydrochloride.
    Bansal BR; Mark R; Mobini J; Rhoads JE; Bansal SC
    J Natl Cancer Inst; 1979 Jul; 63(1):127-32. PubMed ID: 312968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
    Benrezzak O; Madarnas P; Pageau R; Nigam VN
    Anticancer Res; 1988; 8(3):499-506. PubMed ID: 3389753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.